New kidney drug AZD4248 enters early safety testing

NCT ID NCT07024823

First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 21 times

Summary

This early-stage study tests a new drug called AZD4248 in healthy volunteers and people with chronic kidney disease and type 2 diabetes. The main goal is to check if the drug is safe and how the body processes it. The study also looks at whether people can reliably measure their kidney function at home using a simple device.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    RECRUITING

    Glendale, California, 91206, United States

  • Research Site

    RECRUITING

    Chicago, Illinois, 60643, United States

  • Research Site

    RECRUITING

    Ann Arbor, Michigan, 48109, United States

  • Research Site

    RECRUITING

    Saint Paul, Minnesota, 55114, United States

  • Research Site

    RECRUITING

    San Antonio, Texas, 78215, United States

Conditions

Explore the condition pages connected to this study.